Management and Follow-up Results of Salivary Fistulas Treated With Botulinum Toxin.


Journal

The Laryngoscope
ISSN: 1531-4995
Titre abrégé: Laryngoscope
Pays: United States
ID NLM: 8607378

Informations de publication

Date de publication:
02 2019
Historique:
received: 26 01 2018
revised: 13 05 2018
accepted: 06 06 2018
pubmed: 29 8 2018
medline: 24 5 2019
entrez: 29 8 2018
Statut: ppublish

Résumé

Salivary fistulas are a common minor complication of parotid surgery. botulinum toxin has repeatedly been reported to be an adequate treatment of this entity. To date, there is little scientific evidence for clinical decision making after appearance of a salivary fistula. Retrospective chart analysis of 16 patients who had been treated with botulinum toxin for salivary fistula. All patients who had been treated for salivary fistula at a tertiary referral hospital from 2010 to 2016 were included. Patient files were used to obtain characteristics of patients, treatment, and follow-up. Sixteen patients with salivary fistula received 27 injections of botulinum toxin. Nine patients required one injection for the fistula to heal, five patients needed two injections, and one patient needed three and four injections, respectively. No patient underwent additional surgery or radiotherapy. We observed no adverse effects in any patient treated with botulinum toxin. In most cases of salivary fistula, injections of botulinum toxin are a valid treatment. If the initial injection is not successful, injections may be repeated once. Otherwise, revision surgery should be considered. In general, treatment with botulinum toxin should be commenced in an earlier stage and with higher dosages. 4 Laryngoscope, 129:403-408, 2019.

Identifiants

pubmed: 30151958
doi: 10.1002/lary.27416
doi:

Substances chimiques

Neuromuscular Agents 0
Botulinum Toxins, Type A EC 3.4.24.69

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

403-408

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

© 2018 The American Laryngological, Rhinological and Otological Society, Inc.

Auteurs

Thorsten Send (T)

Department of Otorhinolaryngology-Head and Neck Surgery, University Hospital Bonn, Bonn, Germany.

Mattis Bertlich (M)

Department of Otorhinolaryngology-Head and Neck Surgery, University Hospital Munich, Munich, Germany.

Klaus W Eichhorn (KW)

Department of Otorhinolaryngology-Head and Neck Surgery, University Hospital Bonn, Bonn, Germany.

Friedrich Bootz (F)

Department of Otorhinolaryngology-Head and Neck Surgery, University Hospital Bonn, Bonn, Germany.

Mark Jakob (M)

Department of Otorhinolaryngology-Head and Neck Surgery, University Hospital Munich, Munich, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH